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ABSTRACT
EXAMINING DIFFERENTIATING CHARACTERISTICS OF INDIVIDUALS WHO CROSS OVER INTO THE
CRIMINAL JUSTICE SYSTEM IN RELATION TO THEIR SUBSTANCE ABUSE TREATMENT
By
LEYLA COMPANI
March 1, 2017

INTRODUCTION: In Georgia, criminal justice (CJ) involvement is one of the costliest outcomes
experienced by individuals with substance abuse problems. Approximately 8% of individuals in
America have needed substance abuse treatment, and in Georgia CJ involvement commonly cooccurs.
AIM: To examine the transition into the CJ system for those entering treatment, and, arrests of
individuals in treatment. The aim is to determine defining characteristics exist for an individual
who switches over into the CJ system, or an individual who has an arrest while in treatment.
METHODS: Data from the Treatment Episode Data Set from 2011-2015 was examined.
Demographics, drug types, frequency of use, poly drug use, number of treatment episodes,
time between treatment episodes, and rural and urban geography are analyzed in relation to
the dependent study variables. Analytic techniques used are independent samples t-tests and
regression analyses. The dependent variables are any switchover into the criminal justice
system upon reentering treatment, and any arrest before discharge from treatment.
RESULTS: Factors associated with a switch into the CJ system upon admission are noncompletion of high school, ever being unemployed or a student (18 yrs or older), poly drug use,
more than one treatment episode, younger at age of first drug use, longer periods of time in
treatment, a switch of primary drug to meth, crack-cocaine, opiates, marijuana, or alcohol.
Attending self-help programs before entering treatment and living in rural areas also increases
a switch to the CJ system. Higher risk of arrest is associated with younger at age of first drug
use, being male, black or other non-white race, higher education levels, ever being a student or
homeless, attending self-help programs, and living in urban areas.
DISCUSSION: The results and interpretation of this study may help inform and direct one part of
a criminal justice prevention strategy and evidence-based health policy, for individuals who are
undergoing substance abuse treatment.
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Chapter I
Introduction
1.1 Background
In 2015, the National Survey on Drug Use and Health (NSDUH) determined that 8.1%, or 21.7
million people ages 12 or older needed substance abuse treatment in America. (Lipari, ParkLee, & Van Horn, 2016). Georgia, with its population of 10.1 million people (in 2014), faces its
share of the nation’s problem. In 2013, 24,003 individuals received treatment for substance
abuse on any given day in the state (Substance Abuse and Mental Health Services
Administration, 2015). While many of these individuals will have successful outcomes from
these treatment episodes, others run a risk of returning immediately to their abuse cycles and
ultimately ending up involved in the criminal justice (CJ) system. Substance abuse treatment
and CJ involvement are deeply interrelated and CJ involvement is one important outcome
measure of substance abuse treatment. A high proportion of arrestees demonstrate drug
dependence (Garnick et al., 2014) and the odds of offending are three to four times greater for
drug users than those individuals who do not use drugs (Bennett & Holloway, 2005).
Substance abuse is influenced by the characteristics of the communities where individuals
reside, socio-economics, and individual factors (Linton et al., 2016); and individuals may seek
treatment for substance abuse voluntarily, involuntarily, or through court-order. Negative
outcomes from substance abuse include poorer health and the occurrence of chronic health
conditions (Lipari, Park-Lee, & Van Horn, 2016), negative economic impacts to communities, a
strain on government and community resources, and increased risk of individual involvement in
the CJ system (Kissin, Tang, Campbell, Claus & Orwin, 2014). Of these, CJ involvement in
Georgia is one of the most severe and costly outcomes experienced by individuals with
substance abuse problems. The specific concern which sparks this study is the frequency of
transition to involvement in the CJ system of individuals who are directly engaged in treatment,
and a desire to identify what causes the transition.
Several mechanisms operating within an ecologic framework may explain the relationships
between substance abuse treatment and crossover into the CJ system. To date there has been
limited research examining factors that cause an individual who is in and out of substance
abuse treatment to transition into CJ involvement, or cause the arrest of an individual who is
actively engaged in treatment with no prior CJ involvement. Identifying these possible
differentiating characteristics could help public health professionals mitigate the risk of future
offense while decreasing the fiscal and societal burdens associated with criminal justice
involvement for those in substance abuse treatment.
1.2 Societal and Economic Costs
Substance abuse treatment programs have the potential to decrease criminal justice
involvement, and improve the lives of individuals. Per the National Institute on Drug Abuse, in
2012, “every dollar invested in addiction treatment programs yields a return of between $4 and
8

$7 in reduced drug-related crime, CJ costs, and theft. When savings related to healthcare are
included, total savings can exceed costs by a ratio of 12 to 1.” ("Is drug addiction treatment
worth its cost?", 2012). Reduced long-term healthcare costs, social costs, crime-related costs,
and improved job market productivity are key elements that reduce the cost burden to the
state and its residents. Specifically, the burden on law enforcement and public health resources
can be reduced if specific indicators for crossover to the CJ system are explored. Lower hazards
of arrests and CJ involvement due to drug-related and violent crime are found when an
individual is engaged in substance abuse treatment (Garnick et al., 2014).
Outside of individual and public health outcomes, the most immediately important reason for
studying criminal justice involvement as an outcome of substance abuse treatment is its high
cost to the state and its residents (Garnick et al., 2013). Costs to operate the Georgia
Department of Corrections (DOC) and Department of Behavioral Health and Disabilities
(DBHDD), the two state agencies that are most directly involved in the treatment of substance
abuse in its intersection with the CJ system, are very high. The total cost to the DOC for inmates
alone in FY2015 was $1,019,983,078. For probation, the cost in FY2015 was $178,731,524
(Corrections Costs FY2015, 2015). 25% (13,354) of male and 14% (549) of female inmates in
DOC custody in 2015 had some substance abuse issue (Lopez-Howard, Gonzalez & Hafner,
2015). Drug offenders make up 14% of the total inmate population and they comprise one-third
of the total probation population in Georgia. Over $200 million of the DOC budget is dedicated
to Health, which includes constitutionally required physical, dental, and mental health care to
all inmates in the correctional system (Governor's Office of Planning and Budget, 2014).The
substantial portion of inmates with treatment needs and drug related health problems in the
system are significant cost drivers. Furthermore, one-third of referrals for substance abuse
treatment reported to State treatment agencies are from the criminal justice system, which is
the largest source of referrals (Garnick et al., 2014; Substance Abuse and Mental Health
Services Administration, & Office of Applied Studies, 2009).
An additional cost for the state and federal government is through the addiction treatment
funding appropriated to DBHDD. The agency receives the funding under the Prevention and
Treatment of Substance Abuse Block Grant which in FY 2015 amounted to $47,482,075
(Governor's Office of Planning and Budget, 2014).

1.3 Research Questions
The question of what factors, if any, are present that may lead an individual in Georgia who was
in substance abuse treatment to be more likely to switch over to CJ involvement upon reentering substance abuse treatment has not been answered. In addition the factors that may
lead an individual in substance abuse treatment to be arrested before discharge has not been
notably researched. This leads to the question, what are the predictors of this switch to criminal
justice involvement, if any, that increase the likelihood?
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Most commonly, studies begin with a CJ involved population and retrospectively assess existing
or prior substance abuse patterns and history. Others examine the efficacy of drug treatment
programs for CJ involved clients, or the success rate of treatment for this population. This study
however focuses on the predictors, if any, of involvement or admission into the CJ system for
those who are in treatment with no CJ involvement. By focusing on the non-CJ involved
population’s timeline and characteristics through treatment, predictors of CJ involvement can
be illuminated. This will, ideally and with further research, result in risk profile and prevention
protocols to help avoid the critical transition into the CJ system in the first place.

1.4 Definitions
Necessary terminology utilized in this study are as follows:
Admission: “The formal acceptance of a client into substance abuse treatment”, and does not
include referrals, wait-list, or initial screenings. (Substance Abuse and Mental Health Services
Administration, Center for Behavioral Health Statistics and Quality, 2014).
Criminal justice (CJ) involvement: An individual who has been in the system of law
enforcement, the bar, the judiciary, corrections, and probation that is directly involved in the
apprehension, prosecution, defense, sentencing, incarceration, and supervision of those
suspected of or charged with criminal offenses.
Discharge: Occurs when services for the client have been terminated. If a formal discharge has
not occurred, a treatment episode is considered completed as an administrative discharge if
the client, “has not been ‘seen’ in 3 days during inpatient or residential treatment, and 30 days
in the case of outpatient treatment”. (Substance Abuse and Mental Health Services
Administration, Center for Behavioral Health Statistics and Quality, 2014).
Drug Switchover: Defined as the switch from use of one primary drug or substance type for a
substance abuse treatment episode to another primary drug or substance type on the next
substance abuse treatment episode. The use of differing substances or drugs happens
sequentially for each subsequent treatment episode, not concurrently.
Poly Drug Use: Defined in this study as the habitual use of more than one substance or drug
type by an individual when entering treatment. The use of multiple drugs happens
concurrently, not sequentially.
Specialty facility: Substance use treatment at a hospital (inpatient only, a drug or alcohol
rehabilitation facility (inpatient or outpatient), or a mental health center. (Lipari, Park-Lee, &
Van Horn, 2016).
Substance abuse treatment: Admission by an individual to a facility that is required to report
client information to the state substance abuse/behavioral health agency. This includes
detoxification and rehabilitation facilities, and ambulatory treatment services. These may
10

include hospitals, residential treatment facilities, and specialty substance abuse treatment
facilities.
Substance use disorders: When the recurrent use of alcohol and/or drugs causes clinically
significant impairment, including health problems, disability, and failure to meet major
responsibilities at work, school, or home. ("Mental and Substance Use Disorders", 2016).
TEDS: The U.S. Department of Health and Human Services (DHHS), Substance Abuse and
Mental Health Services Administration (SAMHSA), Treatment Episode Data Set A & B, combined
into one data set for this study and discussed more thoroughly in the Methods and Procedures
section.
Treatment Episode: “The period of service between the beginning of a treatment service for a
drug or alcohol problem (admission) and the termination of services for the prescribed
treatment plan (discharge).” (Substance Abuse and Mental Health Services Administration,
Center for Behavioral Health Statistics and Quality, 2014).
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Chapter II
Literature Review
Many studies have examined the TEDS data set, however, no one study has been found to
explicitly examine crossover to the CJ system for those in substance abuse treatment, or
entering substance abuse treatment, with no prior arrests. Similarly, there is a dearth of
studies that examine the TEDS to determine arrests while in treatment, and the possible causal
factors. The majority of studies in this arena generally begin with justice-involved populations,
and chiefly examine recidivism for substance abusers in treatment. Another area of focus are
factors related to success of treatment for those who have been referred by the justice system
or post-imprisonment outcomes for those who have substance abuse issues, or the associations
between drug use and crime. From this lens, however, a framework emerges that can inform
possible risk mitigation by determining risk profiles and factors for those without any prior CJ
involvement who are in treatment.
2.1 Substance Abuse Treatment and Arrest
The effect of substance abuse treatment on criminality has been studied, but limited mostly to
those who abuse opiates. Harris, Jacapraro, & Rastegar (2012) found a two year arrest rate of
38% in a sample of persons in treatment for opiate addiction. A three year prospective study by
Campbell, Deck, & Krupski (2007) examined the impact of substance abuse treatment
(methadone maintenance) on felony/gross misdemeanor arrests among opiate users who were
receiving publicly funded substance abuse services from 1993—2001. The general
demographics of individuals in this study were unmarried Caucasian males, 35 years of age or
older who had a high school degree or equivalent. Heroin was the primary substance used.
Harris, Jacapraro, & Rastegar (2012) cite research and statistics that show a link between
offenders in treatment for opiate abuse and males age 16-34.
The Campbell, Deck, & Krupski, (2007) study is utilizes data from publicly-funded treatment
programs, similar to this study. The authors compare the outcomes of those who did and did
not receive substance abuse treatment. While the population is different than what is
identified for this study, the results are still informative on the impact of treatment on arrest
risk. The study did examine individuals who had no recent history of felony/gross misdemeanor
arrests, and the reduction of arrest risk was stronger than for those individuals who did have
recent histories of arrest(s) when they completed treatment. However, they were both lower
than those who never received treatment. A reduction in risk of arrest was also found in those
who were still in treatment. By the third year of follow up with the individuals, the risk of arrest
for those who had two or more prior arrests was down from a risk rate of 2.8 to 1.8, and for
those with only one prior arrest, the risk declined from 1.9 to 1.4. A higher risk of arrest was
seen in those individuals who had negative outcomes to treatment, such as withdrawing
against advice or relapse. The longer the treatment (90 days or more), risk of arrest declines (p.
515).
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This study shows that substance abuse treatment in itself is a protective factor in minimizing
arrest risk. Anecdotally, the study suggests that law enforcement agencies may target drug
treatment clinics in response to increased levels of drug trafficking in the surrounding areas.
This deliberate targeting could mask the benefits of drug treatment on reducing criminality
(Campbell, Deck, & Krupski, 2007, p. 519). On the whole, substance abuse treatment results in
less involvement in the CJ system: fewer arrests, lower conviction rates, declines in selfreported illegal activities, and lower re-arrest rates (Garnick et al., 2014).
As an example of lower CJ involvement rates, another study done by Merrill, Alterman Cacciola,
& Rutherford (1999) showed similar results as the Campbell, Deck, & Krupski, (2007) study.
Looking at an individual with a heroin addiction’s entire treatment history, a 10% increase in
the number of treatments yielded a 1.8% decrease in the number of arrests, and a 25%
decrease in probability of arrest post-treatment (Merrill, Alterman, Cacciola, & Rutherford,
1999).
2.2 Voluntary Treatment versus CJ Involved Treatment
A study that observes the differences in characteristics and history of individuals who enter
substance abuse treatment voluntarily versus those who are court-mandated was conducted by
Banducci et al. (2013) in Washington State. They found demographic and background
differences in the two groups. Those who entered treatment voluntarily had higher rates of
childhood abuse, emotional abuse, and sexual abuse. Overall, these individuals had higher
rates of “psychiatric disorders, substance dependence, comorbidities and medication
prescriptions” (Banducci et al., 2013). Results of this study also show that people in courtmandated treatment are less likely to drop out of said treatment, which may be in part due to
fear of parole violations or other consequences to leaving treatment. They are also more likely
to be employed and less likely to enter treatment again as compared to those entering
treatment voluntarily.
2.3 Drug Use and Criminal Justice Involvement
A study conducted by Bennett and Holloway (2005) examined the effects of misusing multiple
drugs together, instead of the isolation of one drug, on crime. They believe the direct effects of
mixing drugs on behavior, judgement, and potential amplifying effect on offending are
significant to examine. Bennett and Holloway’s study referenced Chaiken and Chaiken’s 1990
study that demonstrated crime commission rates in the general population to be ten to twenty
times higher for individuals who used multiple drugs four or more times each. Using data
collected as part of the New English and Welsh Arrestee Drug Abuse Monitoring Program
(NEW-ADAM) from 2000-2002, and surveys from 16 custody suites in England and Wales, a
sample size of 3,135 people was analyzed. The majority of the sample was male (86%) and over
the age of 25 (51%). Significant findings show that 69% of multiple drug users had committed
one or more acquisitive crimes in the past year as compared to 38% of those who only used one
drug type. For those who are non-drug users, that percentage was even lower, at 16%. Their
study also showed a significant positive correlation between an increase in the number of drug
types consumed and an increase in the mean number of offenses committed. When examining
drug combinations, Bennett and Holloway’s study showed the highest rates of offending
13

occurred for those individuals who used heroin and crack in combination with “heroin
substitutes, recreational drugs and tranquilizers (Bennett & Holloway, 2005).” They concluded
that while their results were significant, the reasons for their results were not as clear. They
posit three possible explanations for their findings: that multiple drug use causes high rates of
offending; that high rates of offending cause the multiple drug use; and that is a false
relationship with no causal connection, but can be attributed to the lifestyle or disposition of
the individual. The significance of poly drug use on criminal behavior demonstrated in this study
indicates it as an important variable for analysis in determining risk factors for arrest or CJ
switch in the present study.
2.4 Co-Occurring Disorders
In many cases, substance abuse treatment occurs with a mental health disorder. Twenty-seven
percent of Georgia’s prison population are receiving, or have received in the past, some level of
mental health treatment, according to the Georgia Department of Corrections (Georgia
Department of Corrections, 2016). A quarter of male and 14% of female inmates in Georgia
Department of Corrections custody in 2015 had some substance abuse issue as well. (LopezHoward, Gonzalez & Hafner, 2015). In Texas, a study was done to examine the risk of future
offense among probationers with co-occurring mental health and substance abuse disorders.
The majority of study participants were white (56.3%) and male (71.7%), who had an education
level of high school diploma or higher, made less than $20,000 per year, and whose most
common current offense was drug or alcohol related. Calculated measures were scored for
likelihood of future crime and violence. Though a different type of CJ involvement than
incarceration, it was found that probationers were significantly more likely to be at risk when
co-occurring mental health and substance abuse disorders were present, with the highest risk
being for those individuals specifically with bipolar disorder (22.6 times more likely) (Balyakina
et al., 2013). As compared to substance abuse alone, these individuals have a higher risk of
future offense, crime and violence. It is important to highlight the importance of co-occurring
disorders when understanding what factors may lead to future CJ involvement, as 70-80% of
people entering substance abuse treatment present one co-morbid psychiatric disorder
(Steadman et al., 2009; Drug and Alcohol Services Information System, 2001).
The presence of co-occurring disorders seems very likely to have a dramatic impact on a switch
to CJ involvement from a previously uninvolved treatment participant. Unfortunately, the
dataset available at this time does not include information on co-occurrence as a variable, and
as a result it cannot be tested. As such, this variable should be addressed in future studies and
research, as it could substantially inform and expand the results of this study.
2.5 Gender-Sensitive Treatment
The specific needs of women who have substance abuse disorders and arrests differ than those
of men, and their development is often more severe (Kissin, Tang, Campbell, Claus & Orwin,
2014). While the total number of people incarcerated in Georgia has been dropping since 2011,
the percentage of women in Georgia who are incarcerated is steadily increasing. It is higher
than the nationwide average by 7%. According to the Georgia Department of Corrections,
14

9.27% of the prison population in 2011 were women, and this percentage increased to 11.2% in
2014. Forty-five percent of these women had never been incarcerated before (Georgia
Department of Corrections, 2011). While men still make up the majority of those affected by CJ
involvement, this is an important trend to note in future prevention protocols for those in
substance abuse treatment.
According to a study by Salisbury and Van Voorhis offending among women plays out through
three common pathways: childhood victimizations, unhealthy relationships, and financial
problems. These pathways are contributors to mental health disorders, substance abuse and
eventual likelihood of CJ involvement (Salisbury and Van Voorhis, 2009).

2.6 Rural and Urban Impacts
A study by Young, Havens, & Leukefeld (2012) examines differing drug types and use in a rural
Appalachian county and an urban cluster in Kentucky. While not focusing on CJ involvement as
an outcome, the study identified important distinctions in drug use types between rural and
urban settings. The age of first use for those individuals living in a rural Appalachian county (n =
101) for crack, cocaine and opiates was much younger than other drug classes. Rural drug users
also had higher odds of lifetime crack and cocaine use. Urban participants (n = 111) had a
higher odds of recent crack use. This study also draws on a multitude of prior research that
shows higher rates of non-medical drug use and drug related deaths (including poly drug
related deaths) in rural areas that go beyond demographics alone. Nationally, individuals in
opioid treatment programs located in rural areas had higher rates of past 30-day opioid abuse
(Rosenblum et al., 2007). Given the difference between urban and rural populations, this
variable could have an impact on CJ involvement as well, and is well worth including in the
present analysis.
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Chapter III
Methods and Procedures
3.1 Data Source for Study Sample
The Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Treatment
Episode Data Set (TEDS) is a national, de-identified, compilation of data on substance abuse
treatment events. The data are collected by States in monitoring their individual substance
abuse treatment systems. Primarily, it includes information on clients who have been admitted
and discharged from programs that receive public funds. Data from private programs are
included where information is available to the State for reporting.
The TEDS from 2011 to 2015 for Georgia was obtained from the Department of Behavioral
Health and Developmental Disabilities. There are two data sets within TEDS: Admissions (TEDSA) and Discharge (TEDS-D). Admissions data includes information collected at the beginning of a
treatment episode. Discharge data includes information collected at the termination of a
treatment service or episode. Both are obtained for the aforementioned years. Broadly, TEDS
includes demographic, substance abuse, CJ involvement, and socioeconomic characteristics.
27 different TEDS variables that are required to be reported are called the "Minimum Data Set
(MDS)". There are 17 variables that are optional, called the "Supplemental Data Set (SuDS)".
Some of the optional SuDS variables are used in this analysis. By using both Admissions and
Discharge data as endpoints, in addition to any transfer of service data included in the data set,
it is possible to construct a more complete picture of treatment episodes than with Admissions
data alone. This data can be used for comparisons and trends on the characteristics of persons
admitted to and discharged from substance abuse treatment, therefore it is the best source of
raw data to use in determining what criminogenic factors may exist for clients receiving
substance abuse treatment in Georgia. (Substance Abuse and Mental Health Services
Administration, Center for Behavioral Health Statistics and Quality, 2014).
3.2 Procedures
IBM SPSS Version 23 and Microsoft Excel were used to run analyses, and clean or transform
variables. TEDS is structured such that each record is a case, not an individual. Because it is an
admission or discharge case-based system rather than an individual based system, a person
who enters treatment more than once is logged for each treatment episode, not as one
individual with continuous treatment episodes. After merging the admissions and discharge
data set, there were 392,700 cases. The file was restructured by the Client ID variable, which
allowed one to see an entire admission and discharge history for each individual, rather than
looking at separate treatment admission and discharge cases. The restructured dataset
included 128,862 individual records. The maximum number of treatment episodes identified
was thirty. Only two persons had this many admissions. Less than 1% of those in the
restructured dataset (n = 1220) had more than five treatment admissions and discharges. These
outliers were removed, leaving 127,642 (99%) of individuals in the data set. The mean
treatment episode admissions count was 1.42. The standard deviation was 0.965.
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3.3 Statistical Analyses
3.3.1 Demographic Sample
Age is registered in years, as a continuous variable, with the youngest admission at age 3, and
the oldest at age 92, with an average age of 36 years. The percentage of men who entered
substance abuse treatment was 58.7% (n = 74,888) as compared to women (41.3%, n = 52,754).
Whites had the most admissions, at 57% (n = 72,730) with Blacks at 38.7%. Very small
percentages of other races, under 2% for each, also entered treatment. Census data for Georgia
shows that 9.5% of the population in Georgia in 2015 is of Hispanic or Latino origin ("QuickFacts
Georgia", n.d.). The number of individuals of Hispanic or Latino origin entering treatment (2.7%,
n = 3,434) in the sample is much lower than Census numbers. Education was measured by
highest level of school completed, from zero to eighteen years of schooling.
Employment status was categorized by full-time status (40 hours a week), part-time status
(fewer than 30 hours a week), unemployed, and not in the labor force. The majority of the
sample is unemployed (54.3%, n = 69,327) which is expected and consistent when considering
the possible severity of entering substance abuse treatment on an individual’s ability to
maintain consistent employment. This percentage is very high as compared to Georgia’s overall
population. In August 2013, the rate of unemployment for Georgia was 8.7 percent
("QuickFacts Georgia", n.d.). For those who are not in the labor force, disabled individuals made
up a substantial percentage of the data set (20.5%, n = 19,567). Students comprise 5.4% of the
sample (n = 5,156). A very small percentage are homemakers (3.9%, n = 3,745), retired (0.6%, n
= 574), inmate of an institution (1.3%, n = 1,275), or “other” (0.8%, n = 810).
78% of those in the sample live in what are considered to be urban areas (n = 98,584), and 22%
live in rural areas in Georgia (n=27,872). The majority of individuals live independently, but a
substantial percentage have described themselves as ever experiencing or being homeless
across all treatment episodes (8.9%, n = 11,412).
The majority of the sample population have never been married (62.1%, n = 79,288), but a
substantial percentage are divorced (14.9%, n = 19,014) or are married/cohabitating (13.4%, n =
17,084). The percentage of women who were pregnant at the time of admission to treatment
was 1.3%, and made up only 0.5% of the total sample (n = 691). According to the National
Center for Veterans Analysis and Statistics, there were 752,882 veterans living in Georgia in
2014 ("Frequently Asked Questions", 2017). This is 7.5% of Georgia’s population. The number of
veterans who entered substance abuse treatment in the data set was only 1.7% (n = 2,174),
significantly less than the state average. A lower sample size and self-reported data may
account for this disparity. A graphical representation of the demographic sample are displayed
in Table 1, below.
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Table 1.
Demographic Characteristics of the Concatenated Data Set (TEDS-A and TEDS-D)
Variable
Sex
Male
Female
Race
White
Black
Other
Ethnicity
Hispanic
Not Hispanic
Education
Did Not Finish High
School
High School / GED
Higher Education
Pregnant
Yes
No
Living Arrangements
Homeless
Dependent Living
Independent Living
Marital Status
Never Married
Married /Cohabitating
Separated
Divorced
Widowed
Employment Status
Full-Time
Part-Time
Unemployed
Not in Labor Force
Not In Labor Force
Homemaker
Student
Retired
Disabled
Inmate of Institution

Frequency

Percentage

74,888
52,754

58.70
41.30

72,730
49,367
5,545

57
38.7
4.3

3,434
124,208

97.3
2.7

47,122

36.9

50,834
29,686

39.8
23.3

691
126,951

0.5
99.5

12,188
5,186
107,323

9.5
4.1
84.1

79,288
17,084
8,989
19,014
2,380

62.1
13.4
7
14.9
1.9

7,941
5,619
50,625
31,127

6.2
4.4
39.7
24.4

3,745
5,156
574
19,567
1,275

2.9
4
0.4
15.3
1
18

Region Type
Urban
Rural

98,584
27,872

77.2
21.8

*Note: Percentages may not add to 100% due to missing/unknown data.

3.3.2 Variables
Variables are created and recoded in addition to the existing variables in TEDS for the analyses.
3.3.2a Race
The race variable was recoded to three mutually exclusive variables: “White”, “Black”
and “Other”. “Other” represents those who identified as “Asian”, “Alaska Native-Aleut
Eskimo”, “American Indian or Alaska Native”, “Native Hawaiian or Other Pacific
Islander”, “Asian or Pacific Islander”, “Other Single Race”, “Two or More Races” and
those who were of unknown race. These individuals represented a small percentage of
the racial makeup of the data set as a whole (14.3%).
3.3.2b Ethnicity
The ethnicity variable was recoded into a dichotomous variable, “Not of Hispanic or
Latino Origin” and “Hispanic or Latino – Not Specified”. The original data set defines
ethnicity at a more granular level, with categories including “Mexican”, “Puerto Rican”,
“Cuban” and “Other”. Recoding was performed to increase the sample size and
statistical power for those who do identify as Hispanic or Latino, which is still a very
small percentage of the entire data set (2.7%, n=3,434). Only 0.7% (n=881) are of
unknown ethnicity and were excluded from the analysis.
3.3.2c Education
Education is listed in TEDS as a continuous variable, spanning from zero to eighteen
years of education--no schooling at all to completion of a Master’s degree. This variable
was recoded into three mutually exclusive categories: “Did Not Finish High School”
(36.9%, n=47,122), “High School GED” (39.8%, n=50,834) and “Higher Education”
(23.3%, n=29,686). Because individuals have multiple treatment episodes, the highest
grade completed at their last admission was used to calculate education level.
3.3.2d Veteran Status
Veteran status was recoded in such a way as to capture all treatment episodes at
admission— not only the first treatment episode, but also if someone enters treatment
a second, third, fourth or fifth time newly categorized as a veteran. This increased the
number of individuals who reported themselves to be veterans by 115%, from 2,174 to
2,500 across all treatment episodes. Therefore, a final total of 2.0% of individuals in the
data set are reported to be veterans across all treatment episodes (n=2,500).
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3.3.2e Employment Status and Those Not in the Labor Force
The employment status variable was recoded to a dichotomous variable, expressed as
“Ever Unemployed” or “Never Unemployed”. For those who are not in the labor force,
two choices in this variable are extracted for further analyses: students and the
disabled. Preliminary cross-tabulation analysis showed that students had higher
percentages of arrest. Testing for those who are disabled will be done to determine if a
bias toward arrest or criminal justice involvement exists for this population. Two
variables were created from the variable that shows individuals who are not in the labor
force: “Ever Student” and “Ever Disabled”. These variables show who has reported
themselves as a student and/or disabled for their entire treatment episode timeline, not
just for one treatment episode.
3.3.2f Average Time in, and Between, Treatment Episodes
The type of service and treatment setting for a client in the TEDS are listed in eight
categories:
1. 24 hour/day detoxification in a hospital inpatient setting,
2. 24 hour/day detoxification in a free-standing residential setting,
3. rehabilitation/residential setting in a hospital,
4. short-term rehabilitation/residential (thirty days or less) setting,
5. long-term rehabilitation/residential (thirty days or more) setting,
6. Intensive outpatient ambulatory treatment,
7. non-intensive ambulatory outpatient treatment,
8. ambulatory detoxification.
Average time in treatment was calculated by subtracting discharge from admission date
to arrive at a number of days in treatment. A similar process was used to calculate time
between treatment episodes using the admission date at episode – minus admission
date at episode 1 (and so on, up to 5 treatment episodes). Once those individual
treatment lengths were calculated, an average was taken for each individual in the
sample, to capture a snapshot of average time in treatment across all episodes.
Similarly, an average time between treatment episodes was calculated.
3.3.2g Primary Drug Persistence
A dichotomous variable was created (“Primary Drug Persistence”) to determine how
many individuals are seeking treatment for the same primary drug in all of their
treatment episodes. The parameters of this variable require that that an individual have
more than one treatment episode. Only 0.3% of the data set, or 374 people, had
multiple treatment episodes for the same drug or substance type. Therefore, this
variable was not used in the final analysis.
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3.3.2h Poly Drug Use
A poly drug use variable was created (“Poly Drug Use”) to determine which individuals
cite the habitual use of only one drug or substance type, and which individuals cite the
habitual use of more than one drug of substance type.
3.3.2i Drug Switch
Cross-tabulation of all drug and substance types listed in the data set are contrasted
separately with the two primary dependent variables created for the hypotheses, “Any
CJ Switch” and “Any Arrest Before Discharge For All Episodes”. This cross-tabulation
determines which top five drugs had the highest percentages of use for each of the two
variables.
The five drugs with the highest use as they relate to the aforementioned study variables
are methamphetamines, marijuana, alcohol, crack-cocaine and opiates. Heroin was
combined into the opiate group to increase statistical power. Separate variables for
each of these five drugs were then created to illustrate which individuals switched their
primary drug to the drug listed in the variable on their next treatment episode. For
instance, an individual’s first treatment episode was for alcohol abuse. They enter
treatment a second time, but in this instance, for opiate addiction. They will be captured
in the “Opiate Switch” variable. The five variables created to illustrate this switch in
primary drug type are: “Meth Switch,” “Marijuana Switch,” “Crack-Cocaine Switch,”
“Alcohol Switch,” and “Opiate Switch.”
3.3.2j Rural Versus Urban Geography
The county of residence for each individual’s record was provided as a variable in the
data set. To determine if geography has any influence or impact, a variable was created
that coded all the counties in the data set into “rural” or “urban” categories. Rural and
Urban designations for this variable were derived from the Health Resources and
Services Administration (HRSA). HRSA defines rural and urban populations through a
mixture of the U. S. Census Bureau and Office of Management and Budget (OMB)’s
definitions. To this end, “urban” under the U. S. Census Bureau definition is categorized
as “Urbanized Areas of 50,000 or more people and/or urban clusters of at least 2,500
people but less than 50,000 people in Georgia.” ("Defining Rural Population,” 2017). The
OMB definition for an urban cluster differs, at 10,000 people or more but less than
50,000 people, however, OMB still considers these “micropolitan” areas to be rural.
Thus, “rural” is an area that does not meet the defined population numbers of an
“urban” setting--it is the absence of, and not explicitly defined by the U. S. Census
Bureau or the OMB ("Defining Rural Population,” 2017).
3.3.2k Two or More Treatment Episodes
Data on the number of previous treatment episodes that were gathered at each
admission (one through five) was combined and summed to create a variable called
“Maximum Number of Prior Treatments.” This variable was then recoded into a
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dichotomous variable called “Two Plus Treatment Episodes”: those individuals who had
only one treatment episode, and those who had two or more treatment episodes.
3.3.2l Any Criminal Justice Switch
A variable to determine who switched from having no CJ involvement while in
treatment to having CJ involvement at any time from the first treatment admission to
the last discharge was created. This is one of the two primary variables that is tested in
this study. This variable is based on a recode of the referral admission variable. If an
individual was not referred through the courts/criminal justice at treatment 1, but later
referred via this means at treatment 2 or later, they are captured in this variable.
3.3.2m Any Arrest Before Discharge
The TEDS provides information on the number of arrests, for each treatment episode in
the thirty days leading up to discharge. These five variables were combined to create
one variable, named “Any Arrest Before Discharge for All Episodes”, that encompasses
all five treatment episodes for an individual, together, so that one can see the total
number of people who were arrested prior to their discharge from substance abuse
treatment. Some individuals do not have an arrest until their fourth treatment episode,
some have an arrest during their first treatment episode. Therefore, it is important to
capture the sum of arrests for everyone in this timeline.
3.3.2n Motivation for Attending Self Help Programs
Data on the frequency of an individual’s attendance in a self-help program in the thirty
days preceding the date of admission to substance abuse treatment is available as a
variable in the TEDS. This includes attendance at AA, NA, and other self-help and
support groups that focus on recovery from drug and substance dependence. The
variable initially had six categories, ranging from no attendance to 30 days of
attendance in one month. This variable was recoded to determine the cumulative score
of motivation to attend self-help programs across all of an individual’s treatment
episodes. It was then recoded into a dichotomous variable: those who have not
attended self-help programs, and those who have.

3.4 Analytic Plan
Two hypotheses are to be tested. First, that there are independent demographic, time and drug
usage variables that will increase the likelihood that an individual will switch over from not
having criminal justice involvement when first entering substance abuse treatment to having a
criminal justice referral to substance abuse treatment on the next episode. Here, we are testing
our hypothesis at admission with the dependent variable, “Any CJ Switch”. Second, that these
independent demographic, time and drug usage variables will increase the likelihood that an
individual will be arrested in the 30 days leading up to their discharge from substance abuse
treatment, where the individual had no prior criminal justice involvement. Here, we are testing
our hypothesis upon discharge with the dependent variable, “Any Arrest Before Discharge for
All Episodes”.
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These two hypotheses are to be tested using the selected independent existing and created
variables in the data set. The method of analysis is completed via independent samples t-tests,
bivariate correlation, and multivariate logistic regression.

3.4.1 Independent Samples T-Tests
Six independent samples t-tests are analyzed:
1. Any switchover to the CJ system (three tests): measures in differences for those who
entered substance abuse treatment once again but with a criminal justice referral with
reference to:
1. average time in treatment,
2. average time between treatment episodes, and
3. the youngest age at first use for the primary drug or substance type abused.
2. Arrest in the 30 days prior to discharge for any substance abuse treatment episode
(three tests): measures in differences for those who did and did not have an arrest with
respect to:
1. average time in treatment,
2. average time between treatment episodes,
3. the youngest age at first use for the primary drug or substance type abused.
3.4.2 Bivariate Analysis
Bivariate analysis is completed to determine if any correlations exist between the independent
variables and the two primary dependent variables to be tested in the hypotheses. See
Appendix A for full results.
3.4.3 Multivariate Logistic Regressions
Two multivariate logistic regressions are completed—one for each of the hypotheses to be
tested. The independent variables tested in this analysis are sex; race; ethnicity; education
level; veteran status; if an individual was ever unemployed, a student, disabled, or homeless;
poly drug use; two or more treatment episodes; a switch of drug to meth, crack-cocaine,
opiates, marijuana, or alcohol; motivation to attend self-help programs; and living in a rural
area. The two dependent variables in the regression analysis are “Any CJ Switch” and “Any
Arrest Before Discharge for All Treatment Episodes.
3.5 Ethics
The TEDS is a large, de-identified secondary source of data. No privacy issues were broached
and Georgia State University’s Institutional Review Board approved this study.
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Chapter IV
Results
4.1 Descriptive Statistics Results
4.1.1 Average Length of Treatment
The average length of treatment for an individual in all treatment episodes is 14.59 days
(n = 95,302, sd = 91.63). When examining each unique treatment episode, a curve
emerges. On the first treatment episode, the average time in treatment is 12.51 days (n
= 95,306, sd = 91.31). However, on the second, third and fourth treatment episodes, the
length of time in treatment more than doubles to 25.75 days (n = 21,994, sd = 121.62),
31.59 days (n = 6,579, sd = 124.05), and 33.35 days (n = 2,022, sd = 126.23) respectively,
before sharply dropping in the fifth treatment episode to only 4.49 days on average (n =
424, sd = 38.09). See Table 2, below.
Table 2.
Average Length of Treatment in Days
Average

Treatment 1

Treatment 2

Treatment 3

Treatment 4

Treatment 5

95,302

95,306

21,994

6,579

2,022

424

14.6

12.51

25.75

31.59

33.35

4.49

91.63

91.315

121.620

124.054

126.234

38.099

Minimum # Days

0

0

0

0

0

0

Maximum # Days

1,511

1,511

1,394

1,313

1,178

431

N
Mean
Std. Deviation

4.1.2 Average Length of Time Between Treatments
The average length of time between treatment episodes for the entire data set is 320.51
days, on average (n = 31,825, sd = 286.87). When examining the gaps in between
treatments, the length of time between each successive treatment episode decreases.
Between the first and second treatment episode, the average gap in time is 318.22 days
(n = 31,825, sd = 309.63). The length of time between the second and third treatment
episode is 268.18 days (n = 10,103, sd = 260.73). Between the third and fourth
treatment episodes, an average of 230.39 days (n = 3,417, sd = 225.42), and finally,
between the fourth and fifth treatment episodes, an average of 221.44 days (n = 1,005,
sd = 216.19). There is a 43.7% decrease in the length of time in between treatments
from the first to the last treatment episode, or 97 days. See Table 3, below.
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Table 3.
Average Length of Time Between Treatment Episodes
Average

Between 1 and 2

Between 2 and 3

Between 3 and 4

Between 4 and 5

N

31,825

31,825

10,103

3,417

1,005

Mean

320.51

318.22

268.18

230.39

221.44

Minimum # Days

0

0

0

0

0

Maximum # Days

1,450

1,450

1,415

1,253

1,169

4.1.3 Youngest Age at First Use
Descriptive statistics were used to examine the youngest age an individual first used the
primary drug for which they entered treatment, for all their treatment episodes. The
youngest age was at birth, and the oldest age was 99 years old. The average age is 18
years old, median age is 16 (n = 127,642, sd = 11.033).
4.1.4 Two or More Treatment Episodes
81.9% of individuals in the data set have only one prior treatment episode (n = 73,083).
18.9% of individuals have one or more prior treatment episodes (n = 16,126). For each
successive treatment episode, this average steadily increases, from 2.24 prior
treatments on the first treatment episode to 3.30 prior treatments on the fifth
treatment episode. See Table 4.
Table 4.
Two or More Prior Treatment Episodes

N
Average # Prior
Treatment Episodes
Std. Deviation

In Treatment 1

In Treatment 2

In Treatment 3

In Treatment 4

In Treatment 5

127,642

31,825

10,103

3,417

1,005

2.24

2.52

2.87

3.12

3.30

2.923

2.812

2.767

2.741

2.719

4.1.5 Arrest Before Discharge From Treatment
Frequencies were run to determine which individuals had any arrests within 30 days
prior to discharge from that treatment episode, and how many did not have any arrests.
Encompassing all treatment episodes, 4,015 individuals had an arrest in the thirty days
leading up to their discharge from treatment. This number is 3.1% of the data set (n =
127,642).
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4.1.6 Switch to Criminal Justice Involvement Upon Next Treatment Episode Admission
Frequencies were run to determine which individuals had a referral from the criminal
justice system to substance abuse treatment upon their next admission to treatment,
where they did not have any previously. For all treatment episodes, 3,036 individuals
had a switch over. This number is 2.4% of the data set (n = 127,642).
4.1.7 Poly Drug Use
Only 8.9% of the data set includes individuals who have cited only one primary drug or
substance type when they are seeking treatment (n = 11,408). The majority, 91.1%,
habitually use more than one drug or substance type (n = 116,234).
4.1.8 Motivation to Attend Self-Help Programs Prior to Treatment
The majority of individuals in the data set, 90.6%, claim to have never attended any selfhelp programs (n = 115,642). There is a sharp drop-off of individuals who have attended
self-help programs as their number of treatment episodes increases. By the fifth
episode, only one individual attended such programs. The total percentage of those
who have attended self-help programs is 9.4% (n = 12,000).
4.1.9 Primary Drug Switchover
A quarter of the individuals in the data set for each of these variables made a switch into
one of the top five drugs tested in the analysis. The lowest percentage of a drug switch
was for alcohol. Assumptions are made that once an individual is seeking another drug
type, they are ramping up to a drug type with more impact and effect. If an individual is
abusing one drug type already that is not alcohol, alcohol may not be the primary
substance for which they will seek treatment in a subsequent treatment episode.
•
•
•
•
•

Switchover rates:
Switch to methamphetamines: 23.7% (n = 30,200)
Switch to marijuana: 22.3% (n = 28,423)
Switch to crack-cocaine: 23.5% (29,958)
Switch to alcohol: 17.6% (n = 22,486)
Switch to opiates: 23.7% (n = 30,258)

4.2 Results of Switch Over to Criminal Justice Involvement (Admission Analysis)
Results of a person’s admissions to substance abuse treatment (admissions two through five)
are presented to determine if there are significant differences between individuals who did not
have a switch over and those that do.
4.2.1 Average Length of Time Between Treatment Episodes
An independent samples t-test was conducted to examine the differences in length of time in
between substance abuse treatment episodes for those that do not have a switch over into the
criminal justice system on their next treatment episode admission, and those who do. The
group of individuals who do not have a switch over to criminal justice involvement (n=28,789)
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on their next treatment admission had an average length of time between treatment
admissions of 316 days (sd = 288.12). For those that have a switch over to criminal justice
involvement on their next treatment admission (n=3,036), the average length of time between
treatment episodes is longer, at 363 days (sd = 271.11). Equal variances between these two
groups are not assumed based on Levene’s Test for Equality of Variances (p =.000). The
independent samples t-test is associated with a statistically significant effect (t(3,795) = -9.075,
p<.001, Cohen’s d = 0.17). A graphical representation of the means and the 95% confidence
interval are displayed in Table 5. Correlation analysis reveals that there is a significant positive
relationship between the average length of time between treatment episodes and a criminal
justice switch over, r(31,823) = 0.048, p = .000.
Table 5.
Results of a CJ Switch Based on Length of Time Between Treatment Episodes
95% Confidence
Interval of the
Difference
Any CJ
Switch

N

No

28,789

Mean
#
Days
315.99

Yes

3,036

363.23

Std.
Deviation

t

df

288.120

-8.639

31823

Sig.
(2tailed)
.000**

271.111

-9.075

3795.34

.000**

Mean
Difference

Std. Error
Difference

Lower

Upper

-47.237

5.468

-57.954

-36.520

-47.237

5.205

-57.442

-37.031

Two tailed *p<.05, **p<.005

4.2.2 Average Length of Time in Treatment
An independent samples t-test was conducted to examine the differences in the average length
of time in substance abuse treatment for those who do not have a switch over into the criminal
justice system on their next treatment episode admission, and those who do. The group of
individuals who do not have a switch over to criminal justice involvement (n=124,606) on their
next treatment admission had an average length of time in treatment of 13.30 days (sd =
88.10). For those who have a switch over to criminal justice involvement on their next
treatment admission (n=2,956), the average length of time in treatment is longer, at 55 days (sd
= 162.78). Equal variances between these two groups are not assumed based on Levene’s Test
for Equality of Variances (p =.000). The independent samples t-test is associated with a
statistically significant effect (t(3,010) = -13.954, p<.001, Cohen’s d = 0.32). A graphical
representation of the means and the 95% confidence interval are displayed in Table 6.
Correlation analysis reveals that there is a significant positive relationship between the average
length of time between treatment episodes and a criminal justice switch over, r(95,300) =
0.079, p = .000.
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Table 6.
Results of a CJ Switch Based on Length of Time In Treatment
95% Confidence
Interval of the
Difference
Any CJ
Switch

N

No

92,346

Mean
#
Days
13.29

Yes

2,956

55.26

Std.
Deviation

t

88.106

-24.593

162.781

-13.954

df

Sig. (2tailed)

Mean
Difference

Std. Error
Difference

Lower

Upper

95300

.000**

-41.974

3010.67

.000**

-41.974

1.707

-45.319

-38.628

3.008

-47.871

-36.076

Two tailed *p<.05, **p<.005

4.2.3 Average Youngest Age at First Use
An independent samples t-test was conducted to examine the differences in the youngest
average age of first use for those in substance abuse treatment that do not have a switch over
into the criminal justice system on their next treatment episode admission, and those that do.
The group of individuals who do not have a switch over to criminal justice involvement
(n=124,606) on their next treatment admission were, on average, 18.09 years old when they
first used the drug for which they are in treatment (sd = 11.10). For those that have a switch
over to criminal justice involvement on their next treatment admission (n=2,956), the average
age of first use for the drug they are in treatment for is younger, at 16.29 years old (sd = 7.518).
Equal variances between these two groups are not assumed based on Levene’s Test for Equality
of Variances (p =.000). The independent samples t-test is associated with a statistically
significant effect (t(3,365) = 12.859, p<.001, Cohen’s d = 0.19), showing an average age of first
use difference of 1.8 years. A graphical representation of the means and the 95% confidence
interval are displayed in Table 7, below.
Table 7. Any CJ Switch Based on Average Youngest Age of First Use

Any CJ
Switch

N

Mean
Age

Std.
Deviation

T

No

124,606

18.09

11.102

8.887

Yes

3036

16.29

7.518

12.859

df

95% Confidence
Interval of the
Difference
Lower
Upper

Sig. (2tailed)

Mean
Difference

Std. Error
Difference

127640

.000**

1.801

.203

1.403

2.198

3365.809

.000**

1.801

.140

1.526

2.075

Two tailed *p<.05, **p<.005

4.2.4 Multivariate Logistic Regression
The first primary analysis for the study is a multivariate logistic regression to test the impact of
the specified independent variables on a CJ switch. The total number of included individuals in
this regression analysis is 88,372. Of individuals who have more than one treatment episode (n
= 16,126) and therefore could have a CJ switch, 10.5% do have a CJ switch. This accounts for
1.93% of the entire dataset (n = 1,708). Table 8 displays full results of the analysis.
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Interestingly, the analysis shows that sex, race and ethnicity are not statistically significant in
their impact on a CJ switch, whereas they are statistically significant in the second analysis. The
odds ratio (OR) of 0.976 (confidence interval [95% CI] = 0.88-1.08) of sex, with a p value of
0.653 indicates that the difference in being male or female on a CJ switch is not significant.
Blacks have no more of an increased risk to switch into CJ involvement as compared to whites
(OR = 1.00, 95% CI = 0.89-1.12), nor do races categorized as “other” (OR = 1.09, 95% CI = 0.791.51).
Being a veteran also does not have any statistical significance on CJ switch (p = 0.726, OR =
1.06, 95% CI = 0.76-1.49), nor does poly drug use (p = 0.238, OR = 1.24, 95% CI = 0.87-1.78).
The remaining independent variables tested in the regression are all statistically significant. For
education, non-completion of high school or obtaining a GED, the reference group in this
analysis, is significant to CJ switch (p = 0.042). Obtaining a high school diploma or GED shows
potentially decreased odds of a CJ switch by 13% (p = 0.022, OR = 0.87, 95% CI = 0.77-0.98), and
obtaining higher education yields the exact same 13% decrease (p = 0.039, OR = 0.87, 95% CI =
0.76-0.99).
An individual is 77% more likely to have a CJ switch if they have indicated they have ever been
unemployed at admission (p = 0.000, OR = 1.77, 95% CI = 1.33-2.37). Likewise, an individual is
46% more likely to have a CJ switch if they have ever been a student at admission (p =0.002, OR
= 1.46, 95% CI = 1.15-1.85). Labor statistics are gathered for persons over the age of 18,
therefore it is safe to assume that by being a subset of the variable “Not in Labor Force”, a
student is defined as those individuals who have been enrolled in higher education institutions.
Being disabled at admission decreases the likelihood of a CJ switch by 23% (p = 0.000, OR =
0.77, 95% CI = 0.68-0.88). Those individuals who are homeless are also less likely to have a CJ
switch at admission, by 16% (p = 0.017, OR = 0.84, 95% CI = 0.72-0.97).
The number of times an individual has entered substance abuse treatment also has an impact
on CJ switch, with an increase of 15% (p = 0.010, OR = 1.15, 95% CI = 1.04-1.29). Motivation to
attend self-help programs interestingly increases the likelihood of a CJ switch by 23% (p =
0.000, OR = 1.23, 95% CI = 1.13-1.35).
When examining the association from a switch from one primary drug to another, the
likelihood of a CJ switch is very high. A switch to meth from another primary drug increases an
individual’s odds of a CJ switch by 108% (p = 0.000, OR = 2.08, 95% CI = 1.69-2.57). For crackcocaine, the percentage increase is even higher, at 147% (p = 0.000, OR = 2.47, 95% CI = 1.993.07). For a switch of primary drug to marijuana, the increase is higher still, at 150% (p = 0.000,
OR = 2.50, 95% CI = 2.10-2.97). The increased likelihood to switch in to CJ involvement with a
switch to alcohol was 206% (p = 0.000, OR = 3.06, 95% CI = 2.70-3.46). The most astounding
increase in likelihood to criminal justice involvement comes with an individual’s switch of
primary drug to opiates. They are 370% more likely to have a CJ switch (p = 0.000, OR = 4.70,
95% CI = 3.60-6.12).
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Finally, individuals living in a rural area are 11% more likely to have a CJ switch (p = 0.066, OR =
1.11, 95% CI = 0.99-1.24).
Table 8.
Any CJ Switch Multivariate Logistic Regression Analysis Results
95% C.I.for EXP(B)
Variable
Sex

B

S.E.

-.024

.054

.000

.060

Race: Other
Hispanic

.089
-.382

Df

Sig.

.202

1

.653

.289

2

.865

.000

1

.166

.283

.240

2.524

Race: White
Race: Black

Wald

Did Not Finish High School

Exp(B)

Lower

Upper

.976

.879

1.084

.996

1.000

.889

1.124

1

.595

1.093

.789

1.514

1

.112

.683

.426

1.093

6.333

2

.042*

Finished High School / GED

-.143

.062

5.256

1

.022*

.867

.768

.980

Higher Education

-.143

.069

4.257

1

.039*

.867

.757

.993

Ever Veteran

.061

.174

.123

1

.726

1.063

.756

1.495

Ever Unemployed

.571

.148

14.947

1

.000**

1.770

1.325

2.365

Ever Student

.375

.122

9.505

1

.002**

1.455

1.146

1.847

Ever Disabled

-.256

.066

15.223

1

.000**

.774

.681

.880

Ever Homeless

-.178

.075

5.719

1

.017*

.837

.723

.968

Poly Drug Use

.217

.184

1.393

1

.238

1.242

.866

1.782

Two or More Treatment
Episodes

.143

.055

6.693

1

.010*

1.153

1.035

1.285

Switch to Meth

.734

.107

47.468

1

.000**

2.083

1.691

2.567

Switch to Crack-Cocaine

.906

.110

67.985

1

.000**

2.474

1.994

3.068

1.547

.135

130.694

1

.000**

4.697

3.603

6.124

.917

.088

108.351

1

.000**

2.501

2.104

2.972

Switch to Opiates
Switch to Marijuana
Switch to Alcohol

1.118

.063

310.627

1

.000**

3.059

2.701

3.464

Motivation to Attend SelfHelp Programs

.210

.045

22.055

1

.000**

1.234

1.130

1.347

Living in Rural Area

.106

.058

3.378

1

.066

1.112

.993

1.246

Exp(B) is the Odds Ratio.
Exp(B) values statistically significant at the *p<.05, **p<.005 levels.

4.3 Results of Arrest Thirty Days Prior to Discharge (Discharge Analysis)
Individuals with a primary referral source to substance abuse treatment, except from the CJ
system, on their first admission were selected.
4.3.1 Average Length of Time Between Treatment Episodes
Independent samples t-test analysis was conducted to examine the differences in length of
time in between substance abuse treatment episodes for those who do not have an arrest in
the thirty days prior to discharge from treatment, and those who do. The group of individuals
who do not have an arrest (n = 29,741) in the 30 days prior to discharge from treatment had an
average length of time between treatment episodes of 322 days (sd = 288.64). For those
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individuals who do have an arrest in the 30 days prior to discharge from treatment (n = 2,084),
the average length of time between treatment episodes is shorter, at 296 days (sd =259.20).
Equal variances between these two groups are not assumed based on Levene’s Test for Equality
of Variances (p =.000). The independent samples t-test is associated with a statistically
significant effect (t(2,459) = 4.370, p<.001, Cohen’s d = 0.09). A graphical representation of the
means and the 95% confidence interval are displayed in Table 9. Correlation analysis reveals
that there is a significant negative relationship between the average length of time between
treatment episodes and arrest, r(31,823) = -0.022, p = .000.

Table 9.
The Effect of Time Between Treatment Episodes on Arrest While in Treatment

Any Arrest
Before
Discharge
for All
Episodes
No

N

Mean #
Days

Std.
Deviation

29,741

322.199

288.641

3.980

Yes

2084

296.330

259.200

4.370

t

Df

95% Confidence
Interval of the
Difference
Lower
Upper

Sig. (2tailed)

Mean
Difference

Std. Error
Difference

31823

.000**

25.869

6.499

13.130

38.607

2459.424

.000**

25.869

5.919

14.261

37.476

Two tailed *p<.05, **p<.005

4.3.2 Average Length of Time in Treatment
An independent samples t-test analysis was conducted to examine the differences in the
average length of time in substance abuse treatment for those who do not have an arrest in the
30 days prior to discharge from treatment, and those who do. The group of individuals who do
not have an arrest (n=91,288) in the 30 days prior to discharge from treatment had an average
length of time in treatment of 14.6 days (sd = 92.27). For those individuals who do have an
arrest in the 30 days prior to discharge from treatment (n=4,014), the average length of time in
treatment is 13.79 days (sd = 75.78). Equal variances between these two groups is assumed
based on Levene’s Test for Equality of Variances (p =.172). The independent samples t-test is
not associated with a statistically significant effect (t(95,300) = -0.565, p = .572, Cohen’s d =
0.01). A graphical representation of the means and the 95% confidence interval are displayed in
Table 10. Correlation analysis reveals that there is no significant relationship between the
average length of time between treatment episodes and arrest, r(95,300) = -0.002, p = .572.
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Table 10.
Results of Length of Time in Treatment and its Effect on Arrest

Any
Arrest
Before
Discharge
for All
Episodes
No

N

Mean
# Days

Std.
Deviation

91,288

14.632

92.267

.565

Yes

4,014

13.798

75.786

.676

t

df

95%
Confidence
Interval of the
Difference
Lower
Upper

Sig. (2tailed)

Mean
Difference

Std. Error
Difference

95300

.572

0.834

1.478

-2.062

3.731

4552.288

.499

0.834

1.235

-1.586

3.255

Two tailed *p<.05, **p<.005

4.3.3 Average Youngest Age at First Use
An independent samples t-test analysis to examine the differences in the youngest average age
of first use for those in substance abuse treatment for those who do not have an arrest in the
30 days prior to discharge from treatment, and those who do. The group of individuals who do
not have an arrest (n=123,627) in the 30 days prior to discharge from treatment were, on
average, 18.09 years old (sd = 11.07). For those individuals who do have an arrest in the 30 days
prior to discharge from treatment (n=4,014), the average age of first use for the drug they are
in treatment for is also younger, at 16.77 years old (sd = 9.68). Equal variances between these
two groups are not assumed based on Levene’s Test for Equality of Variances (p =.000). The
independent samples t-test is associated with a statistically significant effect (t(4,361) = 8.425, p
< .001, Cohen’s d = 0.13)., showing an average age of first use difference of 1.32 years. A
graphical representation of the means and the 95% confidence interval are displayed in Table
11.

Table 11.
Results of Average Youngest Age of First Use on Arrest While in Treatment

Any Arrest
Before
Discharge
All Episodes
No

N

Mean
Age

Std.
Deviation

123,627

18.09

11.072

7.431

Yes

4,015

16.77

9.683

8.425

t

df

95%
Confidence
Interval of the
Difference
Lower Upper

Sig. (2tailed)

Mean
Difference

Std. Error
Difference

127640

.000**

1.315

.177

.968

1.661

4361.871

.000**

1.315

.156

1.009

1.620

Two tailed *p<.05, **p<.005
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4.3.4 Multivariate Logistic Regression
The second and final analysis for the study is a multivariate logistic regression to test the impact
of specified independent variables on the rate of arrest in the thirty days prior to discharge
from treatment.
In contrast to testing on a CJ switch, sex and race are significant when examining their impact
on an arrest in the 30 days leading up to discharge from substance abuse treatment. Females
are 33% less likely to be arrested (p = 0.000, OR = 0.67, 95% CI = 0.61-0.73). Blacks are 55%
more likely to be arrested while in treatment (p = 0.000, OR = 1.55, 95% CI = 1.41-1.80), as are
individuals categorized as “other” race, by 44% (p = 0.000, OR = 1.44, 95% CI = 1.15-1.80).
Ethnicity is still not a significant factor in arrest during treatment.
For an individual’s education level and its impact on arrest during treatment, finishing high
school or obtaining a GED lowers the risk by 12.6% (p = 0.013, OR = 0.87, 95% CI = 0.79-0.97).
But when examining those who have a higher education level, they are 77% more likely to be
arrested during this time (p = 0.000, OR = 1.77, 95% CI = 1.60-1.96). Individuals who described
themselves as ever being a veteran are 35% less likely to be arrested (p = 0.005, OR = 0.65, 95%
CI = 0.48-0.88).
For those not in the labor force, students in treatment are 73% more likely to be arrested while
in treatment (p = 0.000, OR = 1.46-2.03). Individuals who are homeless have a 35% increased
risk of arrest (p = 0.000, OR = 1.35, 95% CI = 1.19-1.51 Disability status had no significant effect
on likelihood of arrest in the 30 days prior to discharge (p = 0.883, OR 1.00, 95% CI = 0.91-1.12).
Poly drug use and being admitted to substance abuse treatment more than once do not show a
significant impact on arrest during treatment. The motivation to attend self-help programs,
however, is significant. Those individuals are at a 40% increased risk of arrest (p = 0.000, OR =
1.40, 95% CI = 1.29-1.52). Arrests for those in treatment living in rural areas is also significantly
less, showing a 30% decrease as compared to urban areas and clusters (p = 0.000, OR = 0.70,
95% CI = 0.63-0.78).
With a switch of primary drug from one treatment episode to another, four of the top five
drugs tested were not significantly related to likelihood of arrest while in treatment: meth,
crack-cocaine, opiates, or marijuana. The only substance that was significant was alcohol. Those
individuals who were in treatment for one drug, and switched to alcohol in their next treatment
episode are 57% more likely to be arrested while in treatment (p = 0.000, OR = 1.57, 95% CI =
1.37-1.79). See table 12 below for complete results.
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Table 12.
Multivariate Logistic Regression Results on Any Arrest Before Discharge for All Episodes
95% C.I.for EXP(B)
Variable
Sex

B
-.402

S.E.
.045

Race: White

Wald

df

Sig.

79.033

1

.000**

93.984

2

.000**

Exp(B)

Lower

Upper

.669

.612

.731

Race: Black

.437

.045

92.450

1

.000**

1.548

1.416

1.692

Race: Other

.365

.116

9.884

1

.002**

1.441

1.147

1.809

Hispanic

.028

.143

.039

1

.844

1.028

.778

1.360

214.345

2

.000**

Finished High School / GED
Higher Education

-.135
.572

.054
.052

6.237
121.474

1
1

.013*
.000**

.874
1.771

.786
1.600

.971
1.961

Ever Veteran

-.433

.153

8.034

1

.005*

.649

.481

.875

Ever Student

.546

.084

42.301

1

.000**

1.726

1.464

2.034

Ever Disabled

.008

.052

.022

1

.883

1.008

.909

1.117

Ever Homeless

.297

.059

25.240

1

.000**

1.346

1.198

1.511

Poly Drug Use

-.059

.177

.111

1

.738

.943

.667

1.333

Two or More Treatment
Episodes

-.006

.053

.013

1

.909

.994

.895

1.104

Switch to Meth

-.121

.115

1.114

1

.291

.886

.707

1.110

Switch to Crack-Cocaine

.118

.107

1.219

1

.269

1.125

.913

1.388

Switch to Opiates

.161

.120

1.787

1

.181

1.174

.928

1.487

Switch to Marijuana

.126

.087

2.069

1

.150

1.134

.955

1.346

Switch to Alcohol

.452

.068

43.524

1

.000**

1.571

1.374

1.797

Motivation to Attend SelfHelp Programs

.336

.043

61.600

1

.000**

1.400

1.287

1.522

-.356

.056

40.817

1

.000**

.700

.628

.781

Did Not Finish High School

Living in Rural Area

Exp(B) is the Odds Ratio.
Exp(B) values statistically significant at the *p<.05, **p<.005 levels.
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Chapter V
Discussion
5.1 Results
The results of the regression analyses can be roughly broken into two categories: variables that
have common effects between the two tested hypotheses and those that have contrary effects.
5.1.1 Variables with Common Effects
Across the analyses in this study, there are five common factors that increase an individual’s
overall risk of CJ involvement. They are: the longer the time an individual takes in between
treatment episodes, the younger those individuals are the first time they use their primary
drug, if they were ever a student, if they switched their primary drug to alcohol, or if they
attended self-help programs.
The results show that the average age of first use of primary drug is significantly younger for an
individual with CJ involvement (switch or arrest) and is approximately 16 years old. This has a
direct link to educational attainment. These individuals are at an age where they are, or would
be, attending high school. They are using drugs for the first time as teenagers under the age of
18, which can have an effect on high school or GED completion. The relationship of higher
education to student status in the two tested dependent variables appears slightly more
complex. The substantial increase of likelihood of CJ switch and Arrest above for those who
have obtained a higher educational level is somewhat surprising, and potentially indicates the
increase in risky behaviors and lower supervision experienced by college students.
As time goes on, people report having attended self-help less with each subsequent treatment
episode. Frequent and long term attendance of self-help programs, while simultaneously
entering and exiting treatment programs might indicate long term chronic problems that would
increase risk of CJ involvement over time.
5.1.2 Variables with Contrary Effects
It is at first striking that the switch of nearly all primary drugs has an enormous impact on the
likelihood of initiating CJ involvement between treatment episodes, but is not significant to risk
of arrest during treatment. However, upon consideration, the switch of drugs outside of
treatment could be attributed to several factors such as instability, risky behaviors, or
impulsivity that are exactly what active treatment is designed to counter. For instance,
switching drugs might lead a user to a relationship with a new and unknown dealer,
precipitating higher risk. An individual who has switched drugs post treatment has likely
backslid into the behaviors that contributed to their initial drug abuse, but possibly even in an
exacerbated form. Once that individual returns to treatment, the switch of drug choice is less
likely to impact their criminogenic behavior as long as they are a successful participant.
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In line with the above supposition is Bennett & Holloway’s (2005) study showing the strongest
relationship to offending among crack, heroin, and cocaine users where the higher cost to
obtain those drugs in comparison to alcohol and marijuana was a likely contributor to criminal
behavior. Opiates, heroin, and crack cocaine were likewise, by far, the most likely to involve a
CJ switch between treatment episodes in the current study.
Race is not a significant factor in a CJ switch between treatment episodes, however it is a factor
in arrest risk during treatment. This could be a circumstance of individuals entering treatment
without CJ involvement being one population, as opposed to those who are arrested during
treatment who could have already had prior CJ involvement (without a CJ referral to treatment)
that could have increased their likelihood of arrest. Entry into treatment without CJ
involvement is essentially a neutral playing field between races. However when addressing
arrest during treatment, it is likely that the higher probability of law enforcement encounters
experienced by Blacks and other minorities comes into play. In addition, the results show that
there is an increased likelihood of arrest during treatment in urban areas as compared to rural.
Georgia’s urban areas have a higher proportion of black and minority residents.
This makeup of race and ethnicity entering treatment shows a stark contrast to studies by Des
Jarlais et al., in New York City, and Linton et al., in Atlanta. They state that as compared to
Whites, Blacks are less likely to utilize drug treatment despite reporting more severe substance
abuse disorders (Des Jarlais et al., 2013; Linton et al., 2016,). For Blacks in substance abuse
treatment, retention is poorer than Whites (Davey, Latkin, Hua, Tobin, & Strathdee, 2007). If
there is more rapid cycling of Blacks in and out of treatment as compared to Whites, this could
account for the higher percentage of Blacks entering treatment than the racial makeup of
Georgia Census data shows. Point of entry, financial stability, differing racial population
characteristics of other states in the aforementioned study, or other variables could also
possibly account for poorer retention among Blacks.
Many factors could influence a CJ switch for individuals living in rural areas. There could be
greater obstacles to those who live in rural areas that impact their willingness and ability to
admit themselves to substance abuse treatment. For example this could be due to a dearth of
treatment services or programs, lack of transportation, confidentiality concerns, stigmas with
obtaining treatment, or lack of insurance coverage. This can prohibit timely treatment,
exacerbating consequences of drug use and addiction, as well as the severity and negative
implications of substance abuse (Young, Havens, & Leukefeld, 2012). In turn these obstacles can
lead to an arrest in between treatment episodes that results in court referral to treatment,
rather than an arrest while in treatment.
The increased risk of arrest while in treatment for the homeless population could be completely
unrelated to drug abuse or drug-crimes. If a person is in an outpatient treatment setting, their
chances of arrest by police due to simply being homeless is higher because of their potential or
known involvement with illicit subtances. The homeless population is typically greater in urban
areas, and this study does show that there is an increased likelihood of arrest in urban settings
as compared to rural regions.
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An individual having ever been unemployed is a factor in increased odds of a CJ switch,
however, in regard to the arrest variable, there were no individuals who had an arrest who had
never been unemployed and therefore could not be included in that regression analysis. This
combination substantially suggests that consistent employment could be a powerful protector
against CJ involvement. Fisher et al. (2014) posit that the temporal order of substance abuse
and offending is of note when developing prevention protocols, however, this alone ignores
other risk factors that may interplay with substance abuse disorders, such as prior arrest
history, mental health issues, and the use of other drugs. Individuals with substance abuse
disorders who do end up having CJ involvement may need more resources to avoid cycling back
into substance abuse (Garnick et al., 2014). The analyses here indicate that employment
services and vocational training are critical, as are connections to social networks and housing.
5.2 Study Limitations
The TEDS sample that is examined for this study utilizes self-reported data only. While the
information on referral source may be obtained from court documentation, the information on
arrests in the 30 days prior to discharge is based on self-reports. Without linking treatment data
to criminal history data, we cannot know for certain how many persons receiving substance
abuse treatment contact the criminal justice system some time before discharge. Although the
sample spans a five year period and is large, accuracy may be more limited and bias may exist,
especially considering the circumstances at which the information was given by the individual.
Misclassification may have occurred by the facilities or individuals’ self-report. Finally, the data
are fully representative of Georgia as they are a complete population, however, the findings
cannot be generalized to other states.
Care was taken to ensure interpretation of the TEDS did not extend beyond the limitations of
the data. Limitations to the TEDS do exist. An individual’s primary, secondary, and tertiary
substance use which led to treatment are reported to TEDS, and are not necessarily a complete
enumeration of all the substances used at the time of admission.
The primary source of income for individuals in the sample was not made available. Health
insurance data was also not available. Additionally, and perhaps one of the greatest limitations
of this analysis, is that information about co-occurring psychiatric disorders was missing from
the TEDS sample.

5.3 Suggestions for Future Research
This sample did not provide the type of health insurance, if any, that was used for those
entering substance abuse treatment. With the implementation of the Affordable Care Act (ACA)
in 2010, future research could determine the impact, if any, of the ACA on access to treatment,
treatment success and/or retention, and criminal justice outcomes for those in treatment as
compared to a time before ACA legislation was passed.
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Completing a study of co-occuring disorders while in treatment and its effect on CJ involvement
in Georgia might provide another strong indicator of the potential for an individual to transition
in CJ involvement and strengthen the results of this study.

5.4 Conclusion
The results and interpretation of this study may help inform and direct one part of a criminal
justice prevention strategy and evidence-based health policy for individuals who are
undergoing substance abuse treatment. Of particular value are the possible impact of age of
first drug use, unemployment, switching drugs, and any behaviors that increase the likelihood
of an individuals’ risk taking, particularly at a young age. Further study of these interactions and
developing more effective treatment and intervention methods for individuals with these
characteristics could dramatically improve outcomes and decrease burdens on the criminal
justice system in the long-term.
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Appendices
A. CJ Switch Bivariate Analysis
Variables
Any CJ Switch

Any CJ
Switch
Pearson Correlation

1

Sig. (2-tailed)
N
Sex

Pearson Correlation

.003

Sig. (2-tailed)

.215

N
Race

Pearson Correlation
Sig. (2-tailed)
N

Hispanic

Pearson Correlation
Sig. (2-tailed)
N

Education Level

Pearson Correlation
Sig. (2-tailed)
N

Ever Homeless

Pearson Correlation
Sig. (2-tailed)
N

Ever Disabled

Pearson Correlation
Sig. (2-tailed)
N

Ever Student

Pearson Correlation
Sig. (2-tailed)
N

Ever Unemployed

Pearson Correlation
Sig. (2-tailed)
N

Ever Veteran

.000
127642
-.008**
.005
127642
.017**
.000
127642
.051**
.000
127642
.033**
.000
127642
.019**
.000
127642
.082**
.000
127642

Sig. (2-tailed)

.548

Pearson Correlation
N
Pearson Correlation
Sig. (2-tailed)
N

Living in Rural Area

-.013**

.002

Sig. (2-tailed)
Two or More Treatment
Episodes

127642

Pearson Correlation
N

Multiple Drugs Used

127642

Pearson Correlation
Sig. (2-tailed)

127642
.014**
.000
127642
.087**
.000
89209
.008**
.003

43

N
Motivation to Attend
Self-Help Across all
Treatment Episodes

Pearson Correlation
Sig. (2-tailed)
N

Switch to Meth

0.000
.259**

Sig. (2-tailed)

0.000
127642

Pearson Correlation

.264**

Sig. (2-tailed)

0.000
127642

Pearson Correlation

.249**

Sig. (2-tailed)

0.000
127642

Pearson Correlation

.262**

Sig. (2-tailed)

0.000

N
Youngest Age at First
Use for All Admissions

127642

Pearson Correlation

N
Switch to Alcohol

127642

Sig. (2-tailed)

N
Switch to Marijuana

.000

.252**

N
Switch to Opiates

.088**

Pearson Correlation
N

Switch to Crack-Cocaine

126456

Pearson Correlation
Sig. (2-tailed)
N

127642
-.025**
.000
127642

**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).

44

B. Any Arrest Before Discharge for All Treatment Episodes Bivariate Analysis

Variables

Any Arrest Before
Discharge for All
Episodes

Any Arrest
Before
Discharge for
All Episodes
Pearson Correlation
Sig. (2-tailed)
N

Sex

Pearson Correlation
Sig. (2-tailed)
N

Race

Pearson Correlation
Sig. (2-tailed)
N

Hispanic

Pearson Correlation

Pearson Correlation
N
Pearson Correlation
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)
N

Ever Unemployed

.000
127642
.085**
.000
127642
.047**
.000
127642
.029**
.000
127642
0.000

Pearson Correlation

Pearson Correlation
Sig. (2-tailed)
N

Living in Rural Area

.044**

Sig. (2-tailed)

N

Two or More Treatment
Episodes

127642

.105**

Sig. (2-tailed)
Multiple Drug Use

.000
127642

Pearson Correlation
N

Ever Veteran

.041**

.768

Sig. (2-tailed)

Ever Student

.000
127642

.001

N

Ever Disabled

-.031**

Sig. (2-tailed)

Sig. (2-tailed)
Ever Homeless

127642

Pearson Correlation
N

Education Level

1

Pearson Correlation
Sig. (2-tailed)

127642
-.001
.850
127642
.020**
.000
127642
.026**
.000

N

89209

Pearson Correlation

-.036**

Sig. (2-tailed)

.000
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N
Motivation to Attend
Self-Help Across all
Treatment Episodes

Pearson Correlation
Sig. (2-tailed)
N

Switch to Meth

0.000
.109**

Sig. (2-tailed)

0.000
127642

Pearson Correlation

.112**

Sig. (2-tailed)

0.000

Pearson Correlation
N
Pearson Correlation
Sig. (2-tailed)
N

Youngest Age at First
Use for All Admissions

127642

Pearson Correlation

Sig. (2-tailed)
Switch to Alcohol

127642

Sig. (2-tailed)

N
Switch to Marijuana

.000
.111**

N
Switch to Opiates

.096**

Pearson Correlation
N

Switch to Crack

126456

Pearson Correlation
Sig. (2-tailed)
N

127642
.103**
.000
127642
.101**
.000
127642
-.021**
.000
127642

**. Correlation is significant at the 0.01 level (2-tailed).
*. Correlation is significant at the 0.05 level (2-tailed).
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